Zdrowie i gospodarka · 13/06/2025
FDA Classifies Cellular Analysis System for Multiplexed Antimicrobial Susceptibility Testing into Class II Special Controls
The FDA has classified the cellular analysis system for multiplexed antimicrobial susceptibility testing into Class II special controls, aiming to enhance patient access to innovative devices while ensuring safety and effectiveness.